Pharmacological modulation of bronchial hyperreactivity.

Area of Science:

• Respiratory Medicine
• Pharmacology
• Immunology

Background:

• Airway hyperreactivity in asthma involves increased sensitivity to allergens and non-specific stimuli.
• Proposed mechanisms include decreased airway caliber, increased smooth muscle responsiveness, autonomic imbalance, and epithelial changes.
• Understanding these mechanisms is crucial for developing effective asthma treatments.

Purpose of the Study:

• To investigate the mechanisms underlying airway hyperreactivity in asthma.
• To study the effects of mediators and stimuli on lung mechanics and irritant receptor activity.
• To explore pharmacological modulation of airway reactivity.

Main Methods:

• Studied dogs with respiratory tract infections (Bordetella bronchiseptica) and SO2-induced airway damage.
• Assessed airway reactivity to histamine, 5-hydroxytryptamine, and vagal nerve stimulation.
• Examined acute and long-term drug effects on airway responses to non-specific stimuli.

Main Results:

• Increased airway reactivity to histamine in infected dogs was abolished by vagotomy, indicating irritant receptor involvement.
• SO2 exposure enhanced airway responses to 5-hydroxytryptamine and vagal stimulation.
• Long-term sodium cromoglycate treatment inhibited the development of non-specific hyperreactivity in asthmatic patients.

Conclusions:

• Airway hyperreactivity in asthma is associated with increased lung irritant receptor responsiveness and epithelial changes.
• Pharmacological interventions, particularly long-term use of agents like sodium cromoglycate, can modulate and inhibit airway hyperreactivity.
• Further research into these mechanisms can lead to improved therapeutic strategies for asthma management.